We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$25.3B
AUM Growth
+$5.49B
Cap. Flow
+$2.44B
Cap. Flow %
9.65%
Top 10 Hldgs %
19.18%
Holding
3,786
New
851
Increased
1,117
Reduced
1,039
Closed
652

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$142M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$94.7M
3
WDAY icon
Workday
WDAY
+$80M
4
SHW icon
Sherwin-Williams
SHW
+$72.3M
5
MMM icon
3M
MMM
+$60.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.27%
2 Technology 10.11%
3 Healthcare 6.67%
4 Financials 6.57%
5 Industrials 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEAR
3101
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$22.3K ﹤0.01%
+18,865
New +$39.7K
SMSI icon
3102
Smith Micro Software
SMSI
$14M
$21.6K ﹤0.01%
+258
New +$22.5K
EXPR
3103
DELISTED
Express, Inc.
EXPR
$21.4K ﹤0.01%
1,049
-2,101
-67% -$50.1K
AUTL
3104
Autolus Therapeutics
AUTL
$386M
$19.8K ﹤0.01%
+10,407
New +$26.3K
VHC icon
3105
VirnetX Holding Corp
VHC
$52.3M
$19.8K ﹤0.01%
760
-41
-5% -$1.02K
AMRS
3106
DELISTED
Amyris Inc.
AMRS
$19.3K ﹤0.01%
12,618
-17,306
-58% -$38.6K
AFMD
3107
DELISTED
Affimed
AFMD
$18.3K ﹤0.01%
1,474
-71
-5% -$1.25K
BFX
3108
DELISTED
BowFlex Inc.
BFX
$17.4K ﹤0.01%
11,353
-1,534
-12% -$2.44K
MTVA
3109
MetaVia Inc
MTVA
$7.64M
$17.3K ﹤0.01%
+274
New +$118K
BINI
3110
DELISTED
Bollinger Innovations
BINI
0
TOUR
3111
Tuniu
TOUR
$55.4M
$16.3K ﹤0.01%
+1,081
New +$11.9K
PASG icon
3112
Passage Bio
PASG
$15.9M
$16.2K ﹤0.01%
586
+35
+6% +$883
NGD
3113
DELISTED
New Gold Inc
NGD
$16.1K ﹤0.01%
16,400
-9,300
-36% -$9.36K
AVAH icon
3114
Aveanna Healthcare
AVAH
$2.06B
$15.5K ﹤0.01%
19,934
-53,481
-73% -$56K
ASMB icon
3115
Assembly Biosciences
ASMB
$506M
$13.6K ﹤0.01%
+874
New +$14.9K
ARVL
3116
DELISTED
Arrival Ordinary Shares
ARVL
$13.4K ﹤0.01%
1,679
+115
+7% +$2.73K
CELU icon
3117
Celularity
CELU
$21.7M
$13.2K ﹤0.01%
+1,022
New +$18.8K
VLTA
3118
DELISTED
Volta Inc.
VLTA
$12.9K ﹤0.01%
+36,215
New +$27.5K
GRNA
3119
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$12K ﹤0.01%
+10,140
New +$16.5K
ZEV
3120
DELISTED
Lightning eMotors, Inc.
ZEV
$11.8K ﹤0.01%
+1,615
New +$30.9K
ASTR
3121
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$11.5K ﹤0.01%
1,760
-27,556
-94% -$216K
ZOM
3122
DELISTED
Zomedica Corp.
ZOM
$10.2K ﹤0.01%
62,534
+36,700
+142% +$7.52K
TCRT icon
3123
Alaunos Therapeutics
TCRT
$4.74M
$7.47K ﹤0.01%
+77
New +$11.2K
APPH
3124
DELISTED
AppHarvest, Inc. Common Stock
APPH
$6.84K ﹤0.01%
+12,055
New +$15.7K
HYMC icon
3125
Hycroft Mining Holding Corp
HYMC
$1.85B
$5.4K ﹤0.01%
1,015
-3,397
-77% -$21.7K

Similar funds

Squarepoint's Q4 2022 Portfolio in Review

As of Q4 2022, Squarepoint held 3,786 positions worth $25.3B, up 28% from $19.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Squarepoint deployed $2.44B of net new capital in Q4 2022, opening 851 new positions and adding to 1,117 existing holdings. Its largest new stake was Walmart Inc: 3,657,033 shares worth $173M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 10% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Comcast, an estimated $142M trimmed.

  • Squarepoint's largest Q4 2022 buy was Walmart Inc: 3,657,033 shares worth $173M.
  • Squarepoint added most to Apple in Q4 2022, an estimated $252M increase.
  • Squarepoint's biggest Q4 2022 reduction was Comcast, cutting an estimated $142M.
  • Squarepoint fully exited iShares Russell 2000 ETF in Q4 2022, selling an estimated $59.4M.
  • Squarepoint's ten largest holdings make up 19% of its $25.3B portfolio in Q4 2022.
  • Squarepoint opened 851 new positions and closed 652 in Q4 2022.
  • Squarepoint's portfolio value rose 28% quarter-over-quarter to $25.3B.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.